Credit Suisse Maintains Outperform on Encompass Health, Raises Price Target to $80
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Jonathan Yong has maintained an 'Outperform' rating on Encompass Health (NYSE:EHC) and raised the price target from $76 to $80.
August 04, 2023 | 3:28 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Encompass Health's price target has been raised from $76 to $80 by Credit Suisse, maintaining an 'Outperform' rating.
The raised price target and maintained 'Outperform' rating by Credit Suisse indicates a positive outlook for Encompass Health. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100